Brief: NexImmune Collaborates with Herbert Irving Comprehensive Cancer Center
26/04/2022 12:39
April 26 (Reuters) - Neximmune Inc NEXI.O :
* NEXIMMUNE ANNOUNCES PRECLINICAL RESEARCH COLLABORATION
WITH
COLUMBIA UNIVERSITY IRVING MEDICAL CENTER'S HERBERT IRVING
COMPREHENSIVE CANCER CENTER
Source text for Eikon: ID:nGNX2S81db
Further company coverage: NEXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neximmune
See all newsBrief: Neximmune Appointed Albert Marchio As Interim CFO
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting